Cancer Genome Analysis Market, Global Outlook and Forecast 2022-2028

March 2022 | 118 pages | ID: CBB0458FE632EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cancer Genome Analysis in Global, including the following market information:

Global Cancer Genome Analysis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Genome Analysis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Solid Tissue Analysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Genome Analysis include Abbott Diagnostics, AccuraGen Inc, Acuamark Diagnostics, Admera Health, LLC, Agena Bioscience, Inc, Agilent, Almac Diagnostics, Amoy Diagnostics Co., Ltd. and Anchor Dx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Genome Analysis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Genome Analysis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Genome Analysis Market Segment Percentages, by Type, 2021 (%)

• Solid Tissue Analysis
• Liquid Tissue Analysis

Global Cancer Genome Analysis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Genome Analysis Market Segment Percentages, by Application, 2021 (%)

• Clinical
• Pharmaceutical
• Research

Global Cancer Genome Analysis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Genome Analysis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Genome Analysis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Genome Analysis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Diagnostics
• AccuraGen Inc
• Acuamark Diagnostics
• Admera Health, LLC
• Agena Bioscience, Inc
• Agilent
• Almac Diagnostics
• Amoy Diagnostics Co., Ltd.
• Anchor Dx
• ANGLE plc
• ApoCell, Inc.
• ArcherDx, Inc
• Asuragen
• AVIVA Biosciences
• Baylor Miraca Genetics Laboratories
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• BGI Genomics Co. Ltd
• Bioarray Genetics
• Biocartis
• Biocept, Inc
• Biodesix Inc
• BioFluidica
• bioM?rieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc
• Bio-Techne

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Genome Analysis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Genome Analysis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER GENOME ANALYSIS OVERALL MARKET SIZE

2.1 Global Cancer Genome Analysis Market Size: 2021 VS 2028
2.2 Global Cancer Genome Analysis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Genome Analysis Players in Global Market
3.2 Top Global Cancer Genome Analysis Companies Ranked by Revenue
3.3 Global Cancer Genome Analysis Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Analysis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Genome Analysis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Analysis Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Genome Analysis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Analysis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Genome Analysis Market Size Markets, 2021 & 2028
  4.1.2 Solid Tissue Analysis
  4.1.3 Liquid Tissue Analysis
4.2 By Type - Global Cancer Genome Analysis Revenue & Forecasts
  4.2.1 By Type - Global Cancer Genome Analysis Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Genome Analysis Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Genome Analysis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Genome Analysis Market Size, 2021 & 2028
  5.1.2 Clinical
  5.1.3 Pharmaceutical
  5.1.4 Research
5.2 By Application - Global Cancer Genome Analysis Revenue & Forecasts
  5.2.1 By Application - Global Cancer Genome Analysis Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Genome Analysis Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Genome Analysis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Genome Analysis Market Size, 2021 & 2028
6.2 By Region - Global Cancer Genome Analysis Revenue & Forecasts
  6.2.1 By Region - Global Cancer Genome Analysis Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Genome Analysis Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Genome Analysis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Genome Analysis Revenue, 2017-2028
  6.3.2 US Cancer Genome Analysis Market Size, 2017-2028
  6.3.3 Canada Cancer Genome Analysis Market Size, 2017-2028
  6.3.4 Mexico Cancer Genome Analysis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Genome Analysis Revenue, 2017-2028
  6.4.2 Germany Cancer Genome Analysis Market Size, 2017-2028
  6.4.3 France Cancer Genome Analysis Market Size, 2017-2028
  6.4.4 U.K. Cancer Genome Analysis Market Size, 2017-2028
  6.4.5 Italy Cancer Genome Analysis Market Size, 2017-2028
  6.4.6 Russia Cancer Genome Analysis Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Genome Analysis Market Size, 2017-2028
  6.4.8 Benelux Cancer Genome Analysis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Genome Analysis Revenue, 2017-2028
  6.5.2 China Cancer Genome Analysis Market Size, 2017-2028
  6.5.3 Japan Cancer Genome Analysis Market Size, 2017-2028
  6.5.4 South Korea Cancer Genome Analysis Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Genome Analysis Market Size, 2017-2028
  6.5.6 India Cancer Genome Analysis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Genome Analysis Revenue, 2017-2028
  6.6.2 Brazil Cancer Genome Analysis Market Size, 2017-2028
  6.6.3 Argentina Cancer Genome Analysis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Genome Analysis Revenue, 2017-2028
  6.7.2 Turkey Cancer Genome Analysis Market Size, 2017-2028
  6.7.3 Israel Cancer Genome Analysis Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Genome Analysis Market Size, 2017-2028
  6.7.5 UAE Cancer Genome Analysis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Diagnostics
  7.1.1 Abbott Diagnostics Corporate Summary
  7.1.2 Abbott Diagnostics Business Overview
  7.1.3 Abbott Diagnostics Cancer Genome Analysis Major Product Offerings
  7.1.4 Abbott Diagnostics Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.1.5 Abbott Diagnostics Key News
7.2 AccuraGen Inc
  7.2.1 AccuraGen Inc Corporate Summary
  7.2.2 AccuraGen Inc Business Overview
  7.2.3 AccuraGen Inc Cancer Genome Analysis Major Product Offerings
  7.2.4 AccuraGen Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.2.5 AccuraGen Inc Key News
7.3 Acuamark Diagnostics
  7.3.1 Acuamark Diagnostics Corporate Summary
  7.3.2 Acuamark Diagnostics Business Overview
  7.3.3 Acuamark Diagnostics Cancer Genome Analysis Major Product Offerings
  7.3.4 Acuamark Diagnostics Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.3.5 Acuamark Diagnostics Key News
7.4 Admera Health, LLC
  7.4.1 Admera Health, LLC Corporate Summary
  7.4.2 Admera Health, LLC Business Overview
  7.4.3 Admera Health, LLC Cancer Genome Analysis Major Product Offerings
  7.4.4 Admera Health, LLC Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.4.5 Admera Health, LLC Key News
7.5 Agena Bioscience, Inc
  7.5.1 Agena Bioscience, Inc Corporate Summary
  7.5.2 Agena Bioscience, Inc Business Overview
  7.5.3 Agena Bioscience, Inc Cancer Genome Analysis Major Product Offerings
  7.5.4 Agena Bioscience, Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.5.5 Agena Bioscience, Inc Key News
7.6 Agilent
  7.6.1 Agilent Corporate Summary
  7.6.2 Agilent Business Overview
  7.6.3 Agilent Cancer Genome Analysis Major Product Offerings
  7.6.4 Agilent Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.6.5 Agilent Key News
7.7 Almac Diagnostics
  7.7.1 Almac Diagnostics Corporate Summary
  7.7.2 Almac Diagnostics Business Overview
  7.7.3 Almac Diagnostics Cancer Genome Analysis Major Product Offerings
  7.7.4 Almac Diagnostics Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.7.5 Almac Diagnostics Key News
7.8 Amoy Diagnostics Co., Ltd.
  7.8.1 Amoy Diagnostics Co., Ltd. Corporate Summary
  7.8.2 Amoy Diagnostics Co., Ltd. Business Overview
  7.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Major Product Offerings
  7.8.4 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.8.5 Amoy Diagnostics Co., Ltd. Key News
7.9 Anchor Dx
  7.9.1 Anchor Dx Corporate Summary
  7.9.2 Anchor Dx Business Overview
  7.9.3 Anchor Dx Cancer Genome Analysis Major Product Offerings
  7.9.4 Anchor Dx Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.9.5 Anchor Dx Key News
7.10 ANGLE plc
  7.10.1 ANGLE plc Corporate Summary
  7.10.2 ANGLE plc Business Overview
  7.10.3 ANGLE plc Cancer Genome Analysis Major Product Offerings
  7.10.4 ANGLE plc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.10.5 ANGLE plc Key News
7.11 ApoCell, Inc.
  7.11.1 ApoCell, Inc. Corporate Summary
  7.11.2 ApoCell, Inc. Business Overview
  7.11.3 ApoCell, Inc. Cancer Genome Analysis Major Product Offerings
  7.11.4 ApoCell, Inc. Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.11.5 ApoCell, Inc. Key News
7.12 ArcherDx, Inc
  7.12.1 ArcherDx, Inc Corporate Summary
  7.12.2 ArcherDx, Inc Business Overview
  7.12.3 ArcherDx, Inc Cancer Genome Analysis Major Product Offerings
  7.12.4 ArcherDx, Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.12.5 ArcherDx, Inc Key News
7.13 Asuragen
  7.13.1 Asuragen Corporate Summary
  7.13.2 Asuragen Business Overview
  7.13.3 Asuragen Cancer Genome Analysis Major Product Offerings
  7.13.4 Asuragen Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.13.5 Asuragen Key News
7.14 AVIVA Biosciences
  7.14.1 AVIVA Biosciences Corporate Summary
  7.14.2 AVIVA Biosciences Business Overview
  7.14.3 AVIVA Biosciences Cancer Genome Analysis Major Product Offerings
  7.14.4 AVIVA Biosciences Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.14.5 AVIVA Biosciences Key News
7.15 Baylor Miraca Genetics Laboratories
  7.15.1 Baylor Miraca Genetics Laboratories Corporate Summary
  7.15.2 Baylor Miraca Genetics Laboratories Business Overview
  7.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Major Product Offerings
  7.15.4 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.15.5 Baylor Miraca Genetics Laboratories Key News
7.16 Beckman Coulter, Inc.
  7.16.1 Beckman Coulter, Inc. Corporate Summary
  7.16.2 Beckman Coulter, Inc. Business Overview
  7.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Major Product Offerings
  7.16.4 Beckman Coulter, Inc. Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.16.5 Beckman Coulter, Inc. Key News
7.17 Becton, Dickinson and Company
  7.17.1 Becton, Dickinson and Company Corporate Summary
  7.17.2 Becton, Dickinson and Company Business Overview
  7.17.3 Becton, Dickinson and Company Cancer Genome Analysis Major Product Offerings
  7.17.4 Becton, Dickinson and Company Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.17.5 Becton, Dickinson and Company Key News
7.18 BGI Genomics Co. Ltd
  7.18.1 BGI Genomics Co. Ltd Corporate Summary
  7.18.2 BGI Genomics Co. Ltd Business Overview
  7.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Major Product Offerings
  7.18.4 BGI Genomics Co. Ltd Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.18.5 BGI Genomics Co. Ltd Key News
7.19 Bioarray Genetics
  7.19.1 Bioarray Genetics Corporate Summary
  7.19.2 Bioarray Genetics Business Overview
  7.19.3 Bioarray Genetics Cancer Genome Analysis Major Product Offerings
  7.19.4 Bioarray Genetics Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.19.5 Bioarray Genetics Key News
7.20 Biocartis
  7.20.1 Biocartis Corporate Summary
  7.20.2 Biocartis Business Overview
  7.20.3 Biocartis Cancer Genome Analysis Major Product Offerings
  7.20.4 Biocartis Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.20.5 Biocartis Key News
7.21 Biocept, Inc
  7.21.1 Biocept, Inc Corporate Summary
  7.21.2 Biocept, Inc Business Overview
  7.21.3 Biocept, Inc Cancer Genome Analysis Major Product Offerings
  7.21.4 Biocept, Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.21.5 Biocept, Inc Key News
7.22 Biodesix Inc
  7.22.1 Biodesix Inc Corporate Summary
  7.22.2 Biodesix Inc Business Overview
  7.22.3 Biodesix Inc Cancer Genome Analysis Major Product Offerings
  7.22.4 Biodesix Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.22.5 Biodesix Inc Key News
7.23 BioFluidica
  7.23.1 BioFluidica Corporate Summary
  7.23.2 BioFluidica Business Overview
  7.23.3 BioFluidica Cancer Genome Analysis Major Product Offerings
  7.23.4 BioFluidica Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.23.5 BioFluidica Key News
7.24 bioM?rieux Diagnostics
  7.24.1 bioM?rieux Diagnostics Corporate Summary
  7.24.2 bioM?rieux Diagnostics Business Overview
  7.24.3 bioM?rieux Diagnostics Cancer Genome Analysis Major Product Offerings
  7.24.4 bioM?rieux Diagnostics Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.24.5 bioM?rieux Diagnostics Key News
7.25 Bioneer Corporation
  7.25.1 Bioneer Corporation Corporate Summary
  7.25.2 Bioneer Corporation Business Overview
  7.25.3 Bioneer Corporation Cancer Genome Analysis Major Product Offerings
  7.25.4 Bioneer Corporation Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.25.5 Bioneer Corporation Key News
7.26 Bio-Rad Laboratories, Inc
  7.26.1 Bio-Rad Laboratories, Inc Corporate Summary
  7.26.2 Bio-Rad Laboratories, Inc Business Overview
  7.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Major Product Offerings
  7.26.4 Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.26.5 Bio-Rad Laboratories, Inc Key News
7.27 Bio-Techne
  7.27.1 Bio-Techne Corporate Summary
  7.27.2 Bio-Techne Business Overview
  7.27.3 Bio-Techne Cancer Genome Analysis Major Product Offerings
  7.27.4 Bio-Techne Cancer Genome Analysis Revenue in Global Market (2017-2022)
  7.27.5 Bio-Techne Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Genome Analysis Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Analysis Market Drivers in Global Market
Table 3. Cancer Genome Analysis Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Analysis in Global Market
Table 5. Top Cancer Genome Analysis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Genome Analysis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Genome Analysis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Genome Analysis Product Type
Table 9. List of Global Tier 1 Cancer Genome Analysis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Analysis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Genome Analysis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Genome Analysis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Genome Analysis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Genome Analysis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Genome Analysis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Genome Analysis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Genome Analysis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Genome Analysis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Genome Analysis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Genome Analysis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Genome Analysis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Genome Analysis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Genome Analysis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Genome Analysis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Genome Analysis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Genome Analysis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Genome Analysis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Genome Analysis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Genome Analysis Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Diagnostics Corporate Summary
Table 31. Abbott Diagnostics Cancer Genome Analysis Product Offerings
Table 32. Abbott Diagnostics Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 33. AccuraGen Inc Corporate Summary
Table 34. AccuraGen Inc Cancer Genome Analysis Product Offerings
Table 35. AccuraGen Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 36. Acuamark Diagnostics Corporate Summary
Table 37. Acuamark Diagnostics Cancer Genome Analysis Product Offerings
Table 38. Acuamark Diagnostics Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 39. Admera Health, LLC Corporate Summary
Table 40. Admera Health, LLC Cancer Genome Analysis Product Offerings
Table 41. Admera Health, LLC Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 42. Agena Bioscience, Inc Corporate Summary
Table 43. Agena Bioscience, Inc Cancer Genome Analysis Product Offerings
Table 44. Agena Bioscience, Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 45. Agilent Corporate Summary
Table 46. Agilent Cancer Genome Analysis Product Offerings
Table 47. Agilent Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 48. Almac Diagnostics Corporate Summary
Table 49. Almac Diagnostics Cancer Genome Analysis Product Offerings
Table 50. Almac Diagnostics Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 51. Amoy Diagnostics Co., Ltd. Corporate Summary
Table 52. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product Offerings
Table 53. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 54. Anchor Dx Corporate Summary
Table 55. Anchor Dx Cancer Genome Analysis Product Offerings
Table 56. Anchor Dx Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 57. ANGLE plc Corporate Summary
Table 58. ANGLE plc Cancer Genome Analysis Product Offerings
Table 59. ANGLE plc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 60. ApoCell, Inc. Corporate Summary
Table 61. ApoCell, Inc. Cancer Genome Analysis Product Offerings
Table 62. ApoCell, Inc. Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 63. ArcherDx, Inc Corporate Summary
Table 64. ArcherDx, Inc Cancer Genome Analysis Product Offerings
Table 65. ArcherDx, Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 66. Asuragen Corporate Summary
Table 67. Asuragen Cancer Genome Analysis Product Offerings
Table 68. Asuragen Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 69. AVIVA Biosciences Corporate Summary
Table 70. AVIVA Biosciences Cancer Genome Analysis Product Offerings
Table 71. AVIVA Biosciences Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 72. Baylor Miraca Genetics Laboratories Corporate Summary
Table 73. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product Offerings
Table 74. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 75. Beckman Coulter, Inc. Corporate Summary
Table 76. Beckman Coulter, Inc. Cancer Genome Analysis Product Offerings
Table 77. Beckman Coulter, Inc. Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 78. Becton, Dickinson and Company Corporate Summary
Table 79. Becton, Dickinson and Company Cancer Genome Analysis Product Offerings
Table 80. Becton, Dickinson and Company Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 81. BGI Genomics Co. Ltd Corporate Summary
Table 82. BGI Genomics Co. Ltd Cancer Genome Analysis Product Offerings
Table 83. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 84. Bioarray Genetics Corporate Summary
Table 85. Bioarray Genetics Cancer Genome Analysis Product Offerings
Table 86. Bioarray Genetics Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 87. Biocartis Corporate Summary
Table 88. Biocartis Cancer Genome Analysis Product Offerings
Table 89. Biocartis Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 90. Biocept, Inc Corporate Summary
Table 91. Biocept, Inc Cancer Genome Analysis Product Offerings
Table 92. Biocept, Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 93. Biodesix Inc Corporate Summary
Table 94. Biodesix Inc Cancer Genome Analysis Product Offerings
Table 95. Biodesix Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 96. BioFluidica Corporate Summary
Table 97. BioFluidica Cancer Genome Analysis Product Offerings
Table 98. BioFluidica Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 99. bioM?rieux Diagnostics Corporate Summary
Table 100. bioM?rieux Diagnostics Cancer Genome Analysis Product Offerings
Table 101. bioM?rieux Diagnostics Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 102. Bioneer Corporation Corporate Summary
Table 103. Bioneer Corporation Cancer Genome Analysis Product Offerings
Table 104. Bioneer Corporation Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 105. Bio-Rad Laboratories, Inc Corporate Summary
Table 106. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product Offerings
Table 107. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)
Table 108. Bio-Techne Corporate Summary
Table 109. Bio-Techne Cancer Genome Analysis Product Offerings
Table 110. Bio-Techne Cancer Genome Analysis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Genome Analysis Segment by Type in 2021
Figure 2. Cancer Genome Analysis Segment by Application in 2021
Figure 3. Global Cancer Genome Analysis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Genome Analysis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Genome Analysis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genome Analysis Revenue in 2021
Figure 8. By Type - Global Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 12. US Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 24. China Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Genome Analysis Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Genome Analysis Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AccuraGen Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Acuamark Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Admera Health, LLC Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Agena Bioscience, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agilent Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Almac Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Anchor Dx Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ANGLE plc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ApoCell, Inc. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ArcherDx, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Asuragen Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. AVIVA Biosciences Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Beckman Coulter, Inc. Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Becton, Dickinson and Company Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Bioarray Genetics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Biocartis Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Biocept, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Biodesix Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. BioFluidica Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. bioM?rieux Diagnostics Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Bioneer Corporation Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Bio-Techne Cancer Genome Analysis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)